The new vaccines designed to combat the Covid-19 virus have been developed in record time, causing some people to be sceptical of taking them. Should we be worried about side effects? Norwegian SciTech News has been talking to two research scientists about this issue.
Pfizer has recently announced that it is ready with a Covid-19 vaccine that is 90 percent effective. The vaccine is a so-called mRNA vaccine that has been developed jointly by Pfizer and BioNTech. But what is mRNA technology, and how does it work?
Quite a lot of people have modified their exercise habits during the pandemic, but that didn’t affect sleep quality for active people.
The Norwegian University of Science and Technology (NTNU) has signed agreements to deliver as many as one million COVID-19 test kits to DTU, the Technical University of Denmark, and APS LABS, an Indian biotech company. “It is very positive that this technology can now also be useful internationally,” says Bent Høie, Norway’s Minister of Health and Care Services.
One combination of two drugs was so effective that researchers hope others can begin clinical trials on the drugs now.
Testing families of four or more people would be an effective way to reduce the spread of the coronavirus infection, according to a data simulation model developed at NTNU. The model has initially been used to determine the best testing strategy for Oslo.
NTNU researchers recently figured out a whole new method for testing people for the coronavirus. The university is now producing tests on a continuous basis, under the auspices of the Norwegian Directorate of Health. Currently 100 000 tests a day are being manufactured, with production soon likely to be scaled up dramatically.
Italy’s budget deficit is skyrocketing. Yet people there are not debating the cost of a human life, or whether the shutdown of the country is worth it.